Correlation Between Merck and Synaptogenix
Can any of the company-specific risk be diversified away by investing in both Merck and Synaptogenix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Synaptogenix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Synaptogenix, you can compare the effects of market volatilities on Merck and Synaptogenix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Synaptogenix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Synaptogenix.
Diversification Opportunities for Merck and Synaptogenix
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Merck and Synaptogenix is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Synaptogenix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synaptogenix and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Synaptogenix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synaptogenix has no effect on the direction of Merck i.e., Merck and Synaptogenix go up and down completely randomly.
Pair Corralation between Merck and Synaptogenix
Considering the 90-day investment horizon Merck Company is expected to generate 0.23 times more return on investment than Synaptogenix. However, Merck Company is 4.32 times less risky than Synaptogenix. It trades about -0.02 of its potential returns per unit of risk. Synaptogenix is currently generating about -0.04 per unit of risk. If you would invest 10,697 in Merck Company on August 25, 2024 and sell it today you would lose (779.00) from holding Merck Company or give up 7.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Merck Company vs. Synaptogenix
Performance |
| Timeline |
| Merck Company |
| Synaptogenix |
Merck and Synaptogenix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Merck and Synaptogenix
The main advantage of trading using opposite Merck and Synaptogenix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Synaptogenix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synaptogenix will offset losses from the drop in Synaptogenix's long position.| Merck vs. Capricor Therapeutics | Merck vs. Akari Therapeutics PLC | Merck vs. Soleno Therapeutics | Merck vs. Bio Path Holdings |
| Synaptogenix vs. Annovis Bio | Synaptogenix vs. Cyclo Therapeutics | Synaptogenix vs. Reviva Pharmaceuticals Holdings | Synaptogenix vs. INmune Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |